Farnoosh Attari

559 total citations
20 papers, 452 citations indexed

About

Farnoosh Attari is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Farnoosh Attari has authored 20 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Cancer Research and 4 papers in Biomedical Engineering. Recurrent topics in Farnoosh Attari's work include MicroRNA in disease regulation (4 papers), CRISPR and Genetic Engineering (4 papers) and Pluripotent Stem Cells Research (3 papers). Farnoosh Attari is often cited by papers focused on MicroRNA in disease regulation (4 papers), CRISPR and Genetic Engineering (4 papers) and Pluripotent Stem Cells Research (3 papers). Farnoosh Attari collaborates with scholars based in Iran, United States and Italy. Farnoosh Attari's co-authors include Houri Sepehri, Hassan Moghtaderi, Ladan Delphi, Maryam Farzaneh, Fatemeh Rezaei, Seyed Esmaeil Khoshnam, Bahram Goliaei, Paul Mozdziak, Ehsan Arefian and Seyedeh‐Nafiseh Hassani and has published in prestigious journals such as Analytical Biochemistry, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Farnoosh Attari

20 papers receiving 446 citations

Peers

Countries citing papers authored by Farnoosh Attari

Since Specialization

Citations

This map shows the geographic impact of Farnoosh Attari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farnoosh Attari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farnoosh Attari more than expected).

Fields of papers citing papers by Farnoosh Attari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farnoosh Attari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farnoosh Attari. The network helps show where Farnoosh Attari may publish in the future.

Co-authorship network of co-authors of Farnoosh Attari

This figure shows the co-authorship network connecting the top 25 collaborators of Farnoosh Attari. A scholar is included among the top collaborators of Farnoosh Attari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farnoosh Attari. Farnoosh Attari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In-utero transfer of decidualized endometrial stromal cells increases the frequency of regulatory T cells and normalizes the abortion rate in the CBA/J × DBA/2 abortion model 2024 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), Bahman Zeynali, (unknown), (unknown), (unknown), Haleh Soltanghoraee, Ebrahim Mirzadegan, Haleh Edalatkhah, (unknown), (unknown), Farnoosh Attari, Mahmood Jeddi‐Tehrani, Amir‐Hassan Zarnani	3
2	Inhibitory effect of miR342 on the progression of triple-negative breast cancer cells in vitro and in the mice model 2023 ·Bioimpacts ·(unknown), Farnoosh Attari, (unknown), Ehsan Arefian	1
3	Coating of 3D‐printed poly (ε‐caprolactone) scaffolds with silk protein sericin enhances the osteogenic differentiation of human mesenchymal stem cells 2022 ·Polymers for Advanced Technologies ·(unknown), Farnoosh Attari, Ehsan Seyedjafari, Jhamak Nourmohammadi	13
4	Circumventing paclitaxel resistance in breast cancer cells using a nanoemulsion system and determining its efficacy via an impedance biosensor 2021 ·The Analyst ·Farnoosh Attari, (unknown), Ashkan Zandi, (unknown), Hasan Rafati	10
5	Treatment of breast cancer in vivo by dual photodynamic and photothermal approaches with the aid of curcumin photosensitizer and magnetic nanoparticles 2020 ·Scientific Reports ·(unknown), Fatemeh Rezaei, Farnoosh Attari, (unknown)	75
6	Inhibitory effect of flavonoid xanthomicrol on triple‐negative breast tumor via regulation of cancer‐associated microRNAs 2020 ·Phytotherapy Research ·Farnoosh Attari, (unknown), Mohammad Abdollahı, Ehsan Arefian, (unknown), Houri Sepehri, Mahdi Moridi Farimani	19
7	Flavonoid Calycopterin Induces Apoptosis in Human Prostate Cancer Cells In-vitro. 2020 ·Iranian journal of pharmaceutical research ·(unknown), Houri Sepehri, Farnoosh Attari, Ladan Delphi	4
8	Flavonoid calycopterin triggers apoptosis in triple-negative and ER-positive human breast cancer cells through activating different patterns of gene expression 2020 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·(unknown), (unknown), Houri Sepehri, Farnoosh Attari, Ladan Delphi, Ehsan Arefian, Mahdi Moridi Farimani	12
9	The Expression and Functional Roles of miRNAs in Embryonic and Lineage-Specific Stem Cells 2019 ·Current Stem Cell Research & Therapy ·Maryam Farzaneh, (unknown), Zahra Derakhshan, (unknown), Farnoosh Attari, (unknown)	20
10	An electrochemical biosensor to distinguish between normal and cancer cells based on monitoring their acidosis using gold-coated silicon Nano-roughened electrode 2018 ·Analytical Biochemistry ·(unknown), (unknown), Hassan Moghtaderi, (unknown), (unknown), Mona Salimi, Farnoosh Attari, Mohammad Abdolahad	8
11	Gallic acid and curcumin induce cytotoxicity and apoptosis in human breast cancer cell MDA-MB-231 2018 ·Bioimpacts ·Hassan Moghtaderi, Houri Sepehri, Ladan Delphi, Farnoosh Attari	89
12	Concise Review: LIN28/let-7 Signaling, a Critical Double-Negative Feedback Loop During Pluripotency, Reprogramming, and Tumorigenicity 2017 ·Cellular Reprogramming ·Maryam Farzaneh, Farnoosh Attari, Seyed Esmaeil Khoshnam	39
13	Combination of arabinogalactan and curcumin induces apoptosis in breast cancer cells in vitro and inhibits tumor growth via overexpression of p53 level in vivo 2017 ·Biomedicine & Pharmacotherapy ·Hassan Moghtaderi, Houri Sepehri, Farnoosh Attari	66
14	The method of chicken whole embryo culture using the eggshell windowing, surrogate eggshell andex ovoculture system 2017 ·British Poultry Science ·Maryam Farzaneh, Farnoosh Attari, (unknown), Paul Mozdziak	14
15	The evolution of chicken stem cell culture methods 2017 ·British Poultry Science ·Maryam Farzaneh, Farnoosh Attari, Paul Mozdziak, (unknown)	18
16	Generation of Rat Embryonic Germ Cells via Inhibition of TGFß and MEK Pathways. 2015 ·PubMed ·Alireza Mohammadi, Farnoosh Attari, Vahab Babapour, Seyedeh‐Nafiseh Hassani, (unknown), Abdolhossein Shahverdi, Hossein Baharvand	5
17	Efficient Induction of Pluripotency in Primordial Germ Cells by Dual Inhibition of TGF-β and ERK Signaling Pathways 2014 ·Stem Cells and Development ·Farnoosh Attari, Houri Sepehri, Hassan Ansari, Seyedeh‐Nafiseh Hassani, Fereshteh Esfandiari, (unknown), Abdolhossein Shahverdi, Hossein Baharvand	16
18	Inhibition of glycogen synthase kinase-3 promotes efficient derivation of pluripotent stem cells from neonatal mouse testis 2012 ·Human Reproduction ·(unknown), Farnoosh Attari, Abdolhossein Shahverdi, Houri Sepehri, Ali Farrokhi, Seyedeh‐Nafiseh Hassani, Hananeh Fonoudi, Nasser Aghdami, Hossein Baharvand	9
19	STUDY OF APOPTOSIS AND NECROSIS INDUCED BY PECTIC ACID IN GH3/B6 RAT PITUITARY CELL LINE 2009 ·Farnoosh Attari, Houri Sepehri, (unknown), Bahram Goliaei, Ladan Delphi	1
20	Apoptotic and necrotic effects of pectic acid on rat pituitary GH3/B6 tumor cells. 2009 ·PubMed ·Farnoosh Attari, Houri Sepehri, Ladan Delphi, Bahram Goliaei	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact